论文部分内容阅读
目的：观察艾迪注射液联合紫杉醇＋顺铂（TP方案）治疗中晚期非小细胞肺癌（NSCLC）的疗效。方法将54例中晚期非小细胞肺癌随机分为2组，治疗组27例和对照组27例。治疗组采用艾迪注射液联合TP方案治疗；对照组采用TP方案治疗。治疗2个周期结束后观察两组治疗疗效、生活质量及不良反应。结果治疗组总有效率为63．0％，对照组33．3％，2组总有效率比较差异显著（p＜0．05）；治疗组与对照组生活质量评分（KPS）提高率分别是66．7％和37．0％，2组比较差异显著（p＜0．05）；治疗组不良反应明显小于对照组（p＜0．05）。结论艾迪注射液联合TP化疗方案能提高中晚期非小细胞肺癌的疗效，改善患者的生活质量，降低化疗的毒副作用，是临床治疗中晚期NSCLC较好的方案。“,”Objective To evaluate the therapeutic ef ect and adverse reaction of aidi injection combined with TP regimen in treatment of non-smal cel lung cancer(NSCLC).Methods 54 cases of NSCLC were randomly divided into two groups:treatment group(27 cases)were treated with combined therapy of Aidi injection with TP.while control group(27 cases)were treated with TP regimen,The total ef ective rate、the quality of life and adverse reaction were observed after treatment of two cycles.Results The total ef ective rate of treatment group was 63.0%and 33.3%in control group,with significant group diference(p<0.05).The improvement rate of KPS in treatment group was 66.7%and 37.0%in control group,with significant group diference(p<0. 05).The adverse reaction rates of Aidi plus TP were obviously decreased compared with control group(p<0.05).Conclusion The eficacy of Aidi injection combined with TP regimen is bet er than TP regimen alone,and score of quality of life of Aidi injection combined with TP regimen is bet er than TP regimen alone,and the side ef ects are milder in the treatment group than those in the control group.